REQUEST PRICE

Fields with * are required
Any questions? Contact us+49 761-389 49-0
The IVDR comes into effect on 5/25/2022 and provides new rules for homegrown tests (homebrew/LDTs)
Dr. Andreas Eckelt (IVDRconsulting)
• Ravindra Kolhe, MD, PhD • David Fabrizio, PhD • John Jiang, PhD • Yves Konigshofer, PhD
• available On Demand at genomeweb
• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
In this presentation, Ms. Krystyna Nahlik, PhD will present studies on the impact of reference materials on the limit of detection (LoD) and sensitivity in liquid biopsy testing:
- Seraseq® ctDNA Complete
- Seraseq® ctDNA v2
- Seraseq® ctDNA MRD panel
Practical example from the